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Introduction

S
inusitis (rhinosinusitis), an infl ammation of mucous membrane that lines the paranasal sinuses (i.e., airfi lled spaces in the skull and facial bones), is one of the most common health problems worldwide that aff ects 1 in 7 individuals in United States annually. Sinusitis may be acute (lasting for ≤ 4 weeks), chronic (lasting for 4-12 weeks or longer), or recurrent (attacks return several times within 1 year). Quality of life scores for chronic sinusitis is also related with serious illnesses [1, 2] . Sinusitis may be caused by a viral (main cause) or bacterial infection, allergies, air pollution, or dysfunctional nasal morphology. Common sinusitis symptoms include a thick nasal mucus, plugged nasal passages, and facial pain; although, other symptoms including fever, headache, poor sense of smell, sore throat, and cough (worsens at night) have been reported [3] . Current recommendations indicated symptomatic or adjunctive therapies as initial treatment for acute sinusitis [4] . Most sinusitis cases are viral and will resolve without antibiotics within 10 days [5] . However, antibiotics are often administered unnecessarily for such cases. In addition to being ineff ective for viral infection, recurrent antibiotics usage weakens the immune system, causes antibiotic resistance, and can result in a chronic condition.
For chronic sinusitis or symptoms that persist or worsen over 7-10 days, amoxicillin is recommended as the initial treatment of choice for bacterial sinusitis, and corticosteroids may also be helpful. However, surgery may be indicated for resistant chronic or recurring sinusitis [6, 7] . Other complementary treatment choices have been reported, including apitherapy and aqua-puncture [8, 9] . If not treated timely and adequately, sinusitis can lead to serious complications including infl ammation or abscesses of the skull bones, infections of the eye, abscesses under the periosteum or of the orbital, thrombosis of the cavernous sinus, loss of smell, meningitis, and/or epidural, subdural, or other brain abscesses [10] .
Arabic word Al-Hijama means "cupping". Prophet Mohammad (Peace be upon Him) says, "If any of your treatment modalities are benefi cial, the benefi t will be from the blade puncture in cupping therapy, a dose of honey, and cauterization, but I do not like cauterization" [11] .
Currently, cupping therapy is practiced in many countries worldwide [12] . Two main types of cupping therapy are used, including dry and wet [13, 14] . The wet cupping (Al-Hijama, as in Prophetic medicine) comprises a three-step technique involving suction, scarifi cation, and suction. Taibah theory states that AlHijama clears causative pathological substances (CPS) from the blood and interstitial fl uids [15, 16] . Previous studies have found that wet-cupping could successfully treat patients with headache in a primary care setting, and Al-Hijama yields better results when performed at pain sites [17] . Al-Hijama was reported to increase the pharmacological eff ects of drugs, improve the immune system and remove pathogenic, allergenic, and infl ammatory factors from the blood, lymph, and interstitial fl uid. Additionally, previous studies have not reported any complications, caused by correctly performed Al-Hijama [12, 15] .
Cupping is recommended as a complementary treatment modality for many chronic medical conditions. The study aims to compare the effi cacy and safety of Al-Hijama as an adjuvant or alternative to pharmacological therapy versus conventional medical treatment for the symptoms and the use of drugs for sinusitis.
Methods
A randomized controlled clinical trial was conducted at Prophetic Medicine Research Cupping Clinic, King Abdulaziz University (KAU), Jeddah, Saudi Arabia from January 2016 to March 2017. The trial is registered with the National Committee of Biological & Medical Ethics under number HA-02-J-008. The referred patients were divided into three study groups according to the mode of treatment; after which, the author selected 20 patients from each group using a simple randomization technique (fi le number selection). Al-Hijama is clear for both patient and therapist, so trial was not blinded. All adult patients (male or female) diagnosed as chronic or recurrent acute sinusitis, aged between 15 and 65 years, stable cases, were not treated with Al-Hijama for sinusitis before. Sixty patients were divided equally into three groups of 20 patients:
• Group I received Al-Hijama as an adjuvant to the main sinusitis drug therapy.
• Group II received Al-Hijama as main treatment with a salt solution fi ve times per day and mild analgesic as (paracetamol) if needed.
• Group III received conventional sinusitis medication regularly for one week. These treatments were: antibiotics as amoxicillin 500 mg three times a day (TDS) antihistamine once daily, nasal spray containing corticosteroid TDS as fl ixonase or nasonex.
All participants were required to complete the questionnaire regarding symptoms recurrence, duration, presence, and severity. Drug therapies (if used), complimentary treatment use, degree of improvement after medical or Al-Hijama treatment, and the expectation of improvement from Al-Hijama, were graded on a 3-point Likert scale using clear, simple, and closed-ended phrases [18] .
Patients were examined during initial outpatient visits to University Medical Services Center General Clinic at KAU or the Ear, Nose, and Throat (ENT) clinic at KAU Hospital (KAUH). Patients who fulfi lled the inclusion criteria were referred to Prophetic Medicine Clinic, where they completed a questionnaire before cupping and provided written consent. During a onemonth period, patients made three visits to the clinic at two-week intervals. Each session included cupping on 8 points, 6 points wet cupping (above and medial to both eyebrows over sinuses, over 7 th cervical vertebra, 3 cm below it, on both sides of the neck behind and below both ears) and 2 points dry cupping (over sinuses on both sides of the nose above the alae nasal). According to the steps explained in the Taibah theory, shallow scarifi cation incisions (approximately 1-2 mm long and <0.2 mm deep) were made. The patients were re-evaluated after three months, at which time they again completed questionnaires. The data was analyzed using the IBM SPSS Statistics for Windows, Version 20 (IBM Corp., Armonk, NY USA). Qualitative data are expressed as frequencies and percentages.
Results
Seventy-seven patients were referred; however, only 60 patients completed the questionnaire, representing 78% of response rate. 86% of the sample was consisted of Saudi nationals, 60% patients were aged between 36-50 years. 91.6% of the sample were females, 83.3% patients suff ered from allergies, and 80% patients suff ered from sinusitis for more than 3 years. Table 1 presents a comparison of post-treatment symptoms in the three studied groups. Patients in Groups I and II exhibited statistically signifi cant improvements in the frequency, duration, severity and number of symptoms when compared with group III. Table 2 presents a comparison of sinusitis symptoms before and after adding Al-Hijama treatment. Al-Hijama had signifi cant positive eff ects on the frequency, duration, severity, and number of symptoms in both Al-Hijama-treated groups. A p-value < 0.05 is considered signifi cant; a p-value < 0.001 is highly signifi cant (chi-squared test). Table 3 presents a comparison of using medication after treatment in the three studied groups. The groups exhibited highly statistically signifi cant diff erences, with the use of drug therapy increasing in the group treated with medication only. Table 4 demonstrates a comparison of using medications before and after AlHijama treatment. Notably, medication use decreased drastically in both Al-Hijama-treated groups. A p-value < 0.05 was considered signifi cant; a p-value < 0.001 was highly signifi cant (chi-squared test). None of the participants complained of or reported any adverse events after the Al-Hijama treatment.
Discussion
There were no potential sources of bias or limitations during the trial. According to the results, Al-Hijama improved sinusitis symptoms and reduced the use of medication therapy. As shown in Table 1 , patients in both Al-Hijama groups exhibited signifi cant improvements in the frequency, duration, severity, and types of symptoms when compared to patients treated with conventional medication alone. Furthermore, Table 2 revealed signifi cant diff erences in patients' responses regarding the eff ects of Al-Hijama on the rate of sinusitis symptom recurrence. For instance, the rate of multiple recurrences per month was decreased from 85% before treatment to 0% after treatment in Group I and from 75% to 0%, respectively, in Group II; but remained at 55% in Group III. Furthermore, the rate of a single recurrence per three months was increased from 5% to 30% in Group I and from 5% to 30% in Group II, whereas the rate remained at 15% in Group III.
Additionally, patients reported signifi cantly diff erent symptom durations with regard to Al-Hijama usage. For example, the proportion of patients, who reported continuous symptoms, decreased from 30% to 0% in Group I and from 30% to 10% in Group II, whereas the proportion remained at 10% in Group III. The proportion of patients who reported that their symptoms only lasted for hours increased from 5% to 60% in Group I and from 5% to 35% in Group II but remained at 10% in Group III. In other words, the patients' views regarding the level of improvement in symptom quality and severity diff ered signifi cantly and supported the use of Al-Hijama.
The study has compared sinusitis symptoms before and after treatment in two Al-Hijama treated groups and observed no diff erence in outcomes. It has been evaluated that Al-Hijama had a signifi cant positive eff ect on symptom frequency, duration, type, and severity and that the two treatment modalities (pharmacological vs. nasal salt solution) did not yield diff erent outcomes. However, this could indicate the misuse of medications by patients or physicians. Tables 3 and 4 addressed the usage of treatments for sinusitis and related improvements. As shown in Table 3 , a comparison of three studied groups showed Table 3 . Comparison of using medication after treatment among the three studied groups. Table 3 . (Continuation) Comparison of using medication after treatment among the three studied groups. that two groups, treated with Al-Hijama, decreased their use of medication as compared to those treated with medication only. Furthermore, Table 4 shows that both groups treated with Al-Hijama exhibited dramatic decreases in using medication from before to after treatment; specifi cally, 50% no longer required medicine, the rate of antibiotics use decreased from 60% to 10%, the rate of antihistamine use decreased from 80% to 20%, the rate of antihistamine-or cortisonecontaining nasal spray use decreased from 80% to 25%, the rate of analgesic use decreased from 85% to 20%, and the overall rate of complete improvement after medication use increased from 5% to 50%. These results suggested that Al-Hijama has a signifi cantly positive therapeutic eff ect when used either as an adjuvant or as a main treatment for sinusitis.
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Symptoms
Comparison of Safety and
Previous studies have reported fi ndings related directly or indirectly to the subject of current study. In 2003, Zijlstra et al. [19] investigated the eff ect of acupuncture on infl ammatory diseases. In addition, complementary medicine practitioners frequently used acupuncture when treating patients with chronic sinus and nasal symptoms, as demonstrated in several randomized controlled trials. Furthermore, both acupuncture and dry cupping have been recommended as adjunct therapies for allergic rhinitis [20, 21] . Studies, using Al-Hijama for patients with chronic conditions, have reported promising positive eff ects on the health-related quality of life [22] . USA Food and Drug Administration has approved the use of leeches (a type of Al-Hijama) as a means of treatment [23] and Al-Hijama has also been used to treat infl ammatory and allergic diseases and in removing the resulting congestion [24] . Therefore, Al-Hijama appears to be a potentially useful mode of treatment, as it is an eff ective, simple, safe, inexpensive, rapid, and socially acceptable method for reducing sinusitis symptoms and related drug use. The current study is distinct from previous studies that discussed Al-Hijama and acupuncture in terms of the eff ects and roles of similar health problems but did not focus on sinusitis. Regarding limitations, 90% of selected patients are female so there is a potential of bias. Cupping was used with normal saline nasal drops fi ve times a day with analgesic as needed to give synergetic eff ect. Acute cases and chronic mixed should be considered for analysis but mainly depending on patient's feedback on questionnaire, which still show that the eff ect of improvement of symptoms is much better with Al-Hijama. The contribution of this study is emphasized from the signifi cant improvement of symptoms using Al-Hijama based on patient's feedback on questionnaires.
Conclusion
This study demonstrated the marked superiority of Al-Hijama therapy, which is eff ective, simple, safe, aff ordable and not associated with complications, when used correctly, as an adjuvant or alternative treatment for the treatment of sinusitis symptoms. Al-Hijama enhances immune activity and promotes the removal of CPS, and additionally enhances the therapeutic eff ects of medications. Al-Hijama is expected to benefi t every patient; although, the degree of health benefi ts may range from an improvement to a cure. It is expected that health offi cials will offi cially incorporate Al-Hijama into their health care regimens as an adjuvant or alternative treatment for sinusitis patients, as it will reduce the inappropriate use of antibiotics and other medications. Medical staff should be educated about the therapeutic role of Al-Hijama, and Al-Hijama should be practiced by a qualifi ed licensed practitioner (i.e., health offi cial) in hospitals or clinics when indicated or advised. Further investigations are needed to confi rm and verify the benefi cial eff ects of Al-Hijama on the therapeutic outcomes of many diseases, including sinusitis.
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from each patient after completing an interview at the Prophetic Medicine Clinic. Patients were free to withdraw from the research at any time without any eff ects to the provision of services. 
